Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Research Scholarships - Master's program

McMaster University

$27,000.00

Mediating the development of peanut allergies and IgE-mediated anaphylaxis through allergen-degrading bacteria

EF 2025-26

Résumé
Background: Peanut allergies are one of the most common food allergies, with individuals often experiencing severe allergic reactions or anaphylaxis. Currently, there are no preventative strategies available, and the main therapy is peanut avoidance. Although, oral immunotherapy has gained traction for its potential to increase allergen threshold, many patients experience adverse reactions. Therefore, there is a strong need for additional therapies to improve peanut tolerance and reduce IgE responses, including microbial approaches. Previous data in the lab suggests that allergen-degrading bacteria can reduce allergic responses. Objective: To assess whether allergen-degrading bacteria can mediate the initiation of peanut-specific IgE immune responses and whether it can be harnessed to reduce IgE-mediated adverse reactions. Method: To study if intestinal bacteria mediate sensitization, C3H mice with a limited microbiome will be colonized with peanut-degrading Clostridium sporogenes, then sensitized and challenged with peanut. To study whether peanut-degrading probiotics reduce adverse reactions, Specific Pathogen Free C3H mice will be sensitized to peanuts and administered a combination of peanut-degrading Lactobacillus. Mice will then be challenged with peanuts. Systemic IgE, mast cell responses and symptomatology will be determined in all mice. Significance: My project will explore the potential of PN-degrading probiotics to reduce adverse food reactions and improve PN threshold in oral immunotherapy, and inform how microbial allergen metabolism in the gut protects against the onset of food allergies.
Programme
Master's Award: Canada Graduate Research Scholarships - Master's program
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
573152
Name
Coppens Dana
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Mediating the development of peanut allergies and IgE-mediated anaphylaxis through allergen-degrading bacteria
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Adverse Reactions; Allergen Metabolism; Digestive System; Gut Microbiome; Immune System; Mice; Oral Immunotherapy; Peanut Allergies; Probiotics; Sensitization
Abstract
Background: Peanut allergies are one of the most common food allergies, with individuals often experiencing severe allergic reactions or anaphylaxis. Currently, there are no preventative strategies available, and the main therapy is peanut avoidance. Although, oral immunotherapy has gained traction for its potential to increase allergen threshold, many patients experience adverse reactions. Therefore, there is a strong need for additional therapies to improve peanut tolerance and reduce IgE responses, including microbial approaches. Previous data in the lab suggests that allergen-degrading bacteria can reduce allergic responses. Objective: To assess whether allergen-degrading bacteria can mediate the initiation of peanut-specific IgE immune responses and whether it can be harnessed to reduce IgE-mediated adverse reactions. Method: To study if intestinal bacteria mediate sensitization, C3H mice with a limited microbiome will be colonized with peanut-degrading Clostridium sporogenes, then sensitized and challenged with peanut. To study whether peanut-degrading probiotics reduce adverse reactions, Specific Pathogen Free C3H mice will be sensitized to peanuts and administered a combination of peanut-degrading Lactobacillus. Mice will then be challenged with peanuts. Systemic IgE, mast cell responses and symptomatology will be determined in all mice. Significance: My project will explore the potential of PN-degrading probiotics to reduce adverse food reactions and improve PN threshold in oral immunotherapy, and inform how microbial allergen metabolism in the gut protects against the onset of food allergies.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Coppens, Dana
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~